drugset / Trial / NCT00552032

Efficacy and Safety of Mometasone Furoate Nasal Spray in Children With Adenoid Hypertrophy. SNORE Study (P05155)

NCT00552032

Phase 3 Completed 132 enrolled Organon and Co
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether 8 weeks treatment with mometasone furoate nasal spray (MFNS), twice daily, is safe and effective in treating adenoid hypertrophy in children.

Timeline

Start
2007-08-01
Primary completion
2010-01-01
Completion
2010-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Mometasone furoate Other / unclassified 50 ug Intranasal

Indications